Zhang Jianzhen, Bradbury Kathryn Erica, Young Leanne, Gontijo de Castro Teresa
Department of Epidemiology and Biostatistics, School of Population Health, University of Auckland, New Zealand.
Department of Nutrition and Dietetics, School of Medical Sciences, University of Auckland, New Zealand.
Nutr Metab Cardiovasc Dis. 2025 Jan;35(1):103757. doi: 10.1016/j.numecd.2024.09.027. Epub 2024 Sep 26.
The World Health Organization (WHO) recommends that countries reduce industrially produced TFA (iTFA) in the food supply. However, New Zealand (NZ) has no mandatory regulation to control amounts of iTFA in foods. The objectives of this study were to assess within the NZ packaged food supply in recent years (2015-19 and 2022): i) the availability of products displaying information on TFA content on nutrition information panels (NIPs), ii) the content of TFA declared, and iii) the presence/potential presence of iTFA (n = 85,892 products).
A database of packaged foods from major NZ supermarkets was used. TFA contents declared on NIPs were benchmarked against limits recommended by the WHO and the Canadian Trans Fat Task Force. Proportions of products listing specific ingredients (containing iTFA) or non-specific ingredients (potentially containing iTFA) were examined. Trends in proportions were assessed (Mantel-Haenszel tests). Among all products and years examined (n = 81,591), 84.0 % did not display information on TFA content. Across all products declaring TFA contents and years 15.4 % and 6.4 %, respectively, were above the WHO and Canadian TFA limits. Across all products and years, 0.8 % and 13.6 % listed ingredients that contained or potentially contained iTFA, respectively. Across 2015-2019, there was a trend of decrease in the proportions of products listing specific (0.9 %-0.7 %; P = 0.018) and non-specific ingredients (15.1 %-12.8 %; P < 0.001).
Information on the TFA content and ingredients containing iTFA in NZ packaged foods is lacking and ambiguous and government-led interventions to control and reduce TFA in the food supply are warranted.
世界卫生组织(WHO)建议各国减少食品供应中工业生产的反式脂肪酸(iTFA)。然而,新西兰(NZ)没有强制规定来控制食品中iTFA的含量。本研究的目的是评估近年来(2015 - 19年和2022年)新西兰包装食品供应情况:i)在营养信息面板(NIPs)上显示反式脂肪酸含量信息的产品的可得性,ii)申报的反式脂肪酸含量,以及iii)iTFA的存在/潜在存在情况(n = 85,892种产品)。
使用了来自新西兰主要超市的包装食品数据库。将NIPs上申报的反式脂肪酸含量与WHO和加拿大反式脂肪特别工作组推荐的限值进行比对。检查列出特定成分(含iTFA)或非特定成分(可能含iTFA)的产品比例。评估比例趋势(Mantel - Haenszel检验)。在所有检查的产品和年份(n = 81,591)中,84.0%未显示反式脂肪酸含量信息。在所有申报反式脂肪酸含量的产品和年份中,分别有15.4%和6.4%超过了WHO和加拿大的反式脂肪酸限值。在所有产品和年份中,分别有0.8%和13.6%列出了含有或可能含有iTFA的成分。在2015 - 2019年期间,列出特定成分(0.9% - 0.7%;P = 0.018)和非特定成分(15.1% - 12.8%;P < 0.001)的产品比例呈下降趋势。
新西兰包装食品中缺乏关于反式脂肪酸含量和含iTFA成分的信息,且信息不明确,因此有必要采取政府主导的干预措施来控制和减少食品供应中的反式脂肪酸。